The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study to evaluate the efficacy and safety of fruquintinib combined with envafolimab in patients with advanced or unresectable locally advanced osteosarcoma and soft tissue sarcoma.
 
Chenliang Zhou
No Relationships to Disclose
 
Guowei Qian
No Relationships to Disclose
 
Hongtao Li
No Relationships to Disclose
 
Yonggang Wang
No Relationships to Disclose
 
Qingyu Chen
No Relationships to Disclose
 
Zan Shen
No Relationships to Disclose
 
Shuier Zheng
No Relationships to Disclose